Temasek Goes for Another Prize
The next big acquisition by Singapore’s giant sovereign wealth fund, Temasek Holdings, is understood to be a 20-percent stake in the privately controlled Zuellig group, a low-profile but very successful pharmaceutical distributor — the largest in Southeast Asia, say Singapore-based corporate sources.
Zuellig, founded in 1916, is owned by a Swiss family b…
Keep reading with a 7-day free trial
Subscribe to Asia Sentinel to keep reading this post and get 7 days of free access to the full post archives.